This inventor holds 8 USPTO granted patents. Top assignees: Diesse Diagnostica Senese S.r.l., Istituto Sieroterapico E Vaccinogeno Toscano 'Sclavo' S.p.a., Instituto Sieroterapico E Vaccinogeno Toscano 'Sclavo' S.p.a.. Active years: 1980-1994.
Company Filing History:
3 out of 12 
2 out of 5 
1 out of 2 Years Active: 1980-1994
Title: Innovations by Franco Meiattini: Pioneering Urinary Analysis
Introduction
Franco Meiattini is a distinguished inventor based in Siena, Italy, known for his significant contributions to the field of medical diagnostics. With a notable portfolio of eight patents, Meiattini has focused primarily on the development of advanced techniques for detecting and determining bilirubin levels in urine, enhancing both precision and automation in medical testing.
Latest Patents
Among his latest innovations, Meiattini's patents include a comprehensive kit designed for the determination of bilirubin in urine. This kit features a reagent that maintains the pH between 3-7, combining sulfanilic acid or sulfanilamide, a cupric soluble salt, and an alkaline metal nitrite. This stable combination facilitates accurate bilirubin detection, ensuring precise results and supporting the automation of the analytical procedure. Additionally, he has developed a copper-containing reagent that employs the same innovative combination, further enhancing testing accuracy and reliability.
Career Highlights
Throughout his career, Franco Meiattini has collaborated with notable companies such as Diesse Diagnostica Senese S.r.l. and Istituto Sieroterapico e Vaccinogeno Toscano 'Sclavo' S.p.a., where he has played a key role in advancing diagnostic technologies. His passion for innovation has positioned him as a valuable contributor to the medical field, particularly in the diagnostics niche.
Collaborations
Meiattini has also worked alongside esteemed colleagues, including Paolo Tarli and Giorgio Papeschi, fostering a collaborative environment that has led to groundbreaking advancements in urinary analysis. Their joint efforts exemplify the importance of teamwork in pushing the boundaries of medical innovations.
Conclusion
Franco Meiattini's extensive work in the realm of urine analysis reflects a commitment to improving diagnostic methods. His patents not only demonstrate ingenuity but also serve as vital tools in medical testing, ultimately enhancing patient care and outcomes. As he continues to innovate, the impact of his work will undoubtedly be felt across the healthcare landscape.